GENERATION OF NEW CAR T AND BITES TO CONVERT THE TUMOR MICROENVIRONMENT IMMUNOTHERAPY USING ADOPTIVE TRANSFER OF GENETICALLY MODIFIED HUMAN T LYMPHOCYTES TO EXPRESS ANTIGEN-SPECIFIC CHIMERIC RECEPTORS (CAR) Êshare on FacebookTwitterLinkedinEmailreport an issue